Search PDMR transactions

Notifier
Name of person with notification obligation
Jamal El Mosleh
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Jamal El Mosleh
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Elicera Therapeutics AB
Issuer´s LEI code
549300I35L0R4INBFG27
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Elicera Therapeutics AB SE0015382080 Disposal 2,687,000 Quantity 1.28 SEK 20/03/2024 NASDAQ STOCKHOLM AB
Share Elicera Therapeutics AB SE0015382080 Acquisition 2,687,000 Quantity 1.28 SEK 20/03/2024 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Elicera Therapeutics AB SE0015382080 Disposal 20/03/2024 NASDAQ STOCKHOLM AB 2,687,000 (Quantity) 1.28 SEK
Elicera Therapeutics AB SE0015382080 Acquisition 20/03/2024 NASDAQ STOCKHOLM AB 2,687,000 (Quantity) 1.28 SEK
<< Back